.png){kind=icon}
.png){kind=icon}
Return
Time to Insulin Initiation Among Patients With Type 2 Diabetes Treated With Second-Line Antidiabetic Drugs
.png){kind=icon}
OA
AI
Y
Q
E
R
P
O
K
DOI：10.1111/dom.71182.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
To examine the effect of second-line treatments (insulin secretagogues, thiazolidinediones, glucagon-like peptide-1 (GLP-1) receptor agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose co-transporter 2 (SGLT-2) inhibitors) on time to insulin initiation among patients with type 2 diabetes.
Keywords:
insulin initiation
population-based cohort study
second-line antidiabetic medication
type 2 diabetes
UK
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
D
IF:
5.7
Papers:
372
Citations:
0
Organization
Cited Papers